Cytostatic and cytotoxic properties of monensic acid and its biometal(II) complexes against human tumor / non-tumor cell lines

• Authors: Radostina Alexandrova , Tanya Zhivkova , Marin Alexandrov , Georgi Miloshev , Milena Georgieva , Ivayla Pantcheva , Mariana Mitewa
• Languages of publication: EN

Abstracts

EN

The anticancer activity of monensic acid (MonH) and its biometal(II) complexes [M(Mon)2(H2O)2](M = Mg, Ca, Mn, Co, Ni, Zn) was evaluated against cultured human permanent cell lines established from glioblastoma multiforme (8MGBA) and cancers of the lung (A549), breast (MCF-7), uterine cervix (HeLa) and liver (HepG2). The viability and proliferation of the non-tumor human embryonic cell line Lep3 was also tested. The investigations were carried out using a thiazolyl blue tetrazolium bromide test, neutral red uptake cytotoxicity assay, crystal violet staining, colony forming method and double staining with acridin orange and propidium iodide. The results obtained reveal that the compounds applied at concentrations of 0.5–25 µg mL−1 for 24–72 h decrease the viability and proliferation of the treated cells in a time- and concentration-dependent manner. The metal(II) complexes studied (especially those of Co(II), Ni(II) and Zn(II)) have been found to express stronger cytotoxic and cytostatic activities than the non-coordinated monensic acid. The non-tumor human cell line showed strong chemosensitivity towards compounds tested comparable to that of cultured human tumor cell lines. [...]

Keywords

EN

Human cancer cell lines; Monensin biometal(II) complexes; Cytotoxic / Antiproliferative effect

• Publisher: De Gruyter Open
• Journal: Open Chemistry
• Year: 2012
• Volume: 10
• Issue: 5
• Pages: 1464-1474

Dates

published

1 - 10 - 2012

online

21 - 7 - 2012

Contributors

author

Radostina Alexandrova

• Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, 1113, Sofia, Bulgaria

author

Tanya Zhivkova

• Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, 1113, Sofia, Bulgaria

author

Marin Alexandrov

• Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, 1113, Sofia, Bulgaria

author

Georgi Miloshev

• Institute of Molecular Biology, Bulgarian Academy of Sciences, 1113, Sofia, Bulgaria

author

Milena Georgieva

• Institute of Molecular Biology, Bulgarian Academy of Sciences, 1113, Sofia, Bulgaria

author

Ivayla Pantcheva

• Department of Analytical Chemistry, Faculty of Chemistry and Pharmacy, Sofia University, 1164, Sofia, Bulgaria

author

Mariana Mitewa

• Department of Analytical Chemistry, Faculty of Chemistry and Pharmacy, Sofia University, 1164, Sofia, Bulgaria

References

• [1] A. Agtarap, J.W. Chamberlin, M. Pinkerton, L.K. Steinrauf, J. Am. Chem. Soc. 89, 5737 (1967) http://dx.doi.org/10.1021/ja00998a062[Crossref]
• [2] B.C. Pressman, Ann. Rev. Biochem. 45, 501 (1976) http://dx.doi.org/10.1146/annurev.bi.45.070176.002441[Crossref]
• [3] P.H. Stern, Clin. Orthop. Rel. Res. 122, 273 (1977)
• [4] P.C. Augustine, C.K. Smith, H.D. Danforth, M.D. Ruff, Poultry Sci. 66, 960 (1987) http://dx.doi.org/10.3382/ps.0660960[Crossref]
• [5] S.D. Folz, B.L. Lee, L.H. Nowakowski, G.A. Conder, Vet. Parasit. 28, 1 (1988) http://dx.doi.org/10.1016/0304-4017(88)90013-1[Crossref]
• [6] D.A. Kevin II, D.A.F. Meujo, M.T. Hamann, Exp. Opi. Drug Discov. 4, 109 (2009) http://dx.doi.org/10.1517/17460440802661443[Crossref]
• [7] B.G. Cox, N. van Truong, J. Rzeszotarska, H. Schneider, J. Chem. Soc., Faraday Trans. I 80, 3275 (1984) http://dx.doi.org/10.1039/f19848003275[Crossref]
• [8] M. Mimouni, S. Perrier, I. Pointud, J. Juillard, J. Sol. Chem. 22, 769 (1993) http://dx.doi.org/10.1007/BF00648581[Crossref]
• [9] M. Mimouni, M. Hebrant, G. Dauphin, J. Juillard, J. Chem. Res. S6, 278 (1996)
• [10] F.G. Riddell, Chirality 14, 121 (2002) http://dx.doi.org/10.1002/chir.10052[Crossref]
• [11] W.H. Park et al., Intern. J. Cancer 101, 235 (2002) http://dx.doi.org/10.1002/ijc.10592[Crossref]
• [12] W.H. Park et al., Brit. J. Haem. 119, 400 (2002) http://dx.doi.org/10.1046/j.1365-2141.2002.03834.x[Crossref]
• [13] W.H. Park et al., Intern. J. Oncol. 22, 377 (2003)
• [14] W.H. Park et al., Intern. J. Oncol. 22, 855 (2003)
• [15] W.H. Park, E.S. Kim, B.K. Kim, Y.Y. Lee, Intern. J. Oncology 23, 197 (2003)
• [16] J. Basque, M. Martel, R. Leduc, A.M. Cantin, Can. J. Physiol. Pharmacol. 86, 606 (2008) http://dx.doi.org/10.1139/Y08-063[Crossref]
• [17] G.C. Blobe, W.P. Schiemann, H.F. Lodish, N. Engl. J. Med. 342, 1350 (2000) http://dx.doi.org/10.1056/NEJM200005043421807[Crossref]
• [18] T. Griffin et al., J. Natl. Cancer Inst. 85, 292 (1993) http://dx.doi.org/10.1093/jnci/85.4.292[Crossref]
• [19] M.S. Shaik, T.L. Jackson, M. Singh, J. Pharm. Pharmacol. 55, 819 (2003) http://dx.doi.org/10.1211/002235703765951438[Crossref]
• [20] M. Wu, Br. J. Cancer. 75, 1347 (1997) http://dx.doi.org/10.1038/bjc.1997.228[Crossref]
• [21] M. Sehested, T. Skovsgaard, H. Roed, Biochem. Pharmacol. 37, 3305 (1988) http://dx.doi.org/10.1016/0006-2952(88)90643-0[Crossref]
• [22] W.D. Klohz, R.W. Steinkampf, Mol. Pharmacol. 34, 180 (1988)
• [23] N.K. Chirase, L.W. Greene, G.T. Schelling, F.M. Byers, J. Anim. Sci. 65, 1633 (1987)
• [24] K.A. Johnson, Diss. Abstr., Intern. B Sci. Eng. 48, 1855 (1988)
• [25] S.A. Hamidinia et al., J. Biol. Chem. 277, 38111 (2002) http://dx.doi.org/10.1074/jbc.M205590200[Crossref]
• [26] I.N. Pantcheva et al., Curr. Drug Discov. Techn. 5, 154 (2008) http://dx.doi.org/10.2174/157016308784746247[Crossref]
• [27] I.N. Pantcheva et al., BioMetals 23, 59 (2010) http://dx.doi.org/10.1007/s10534-009-9269-5[Crossref]
• [28] I.N. Pantcheva et al., Inorg. Chim. Acta 363, 1879 (2010) http://dx.doi.org/10.1016/j.ica.2010.02.009[Crossref]
• [29] J. Ivanova et al., Centr. Eur. J. Chem. 8, 852 (2010) http://dx.doi.org/10.2478/s11532-010-0067-2[Crossref]
• [30] R.I. Alexandrova, T. Zhivkova, I.N. Pantcheva, M.Io. Mitewa, Intern. J. Biol. Biomed. Eng. 5, 93 (2011)
• [31] M. R. Boyd, In: B. Teicher (Ed.), Anticancer Drug Development Cuide: Preclinical Screening, Clinical Trials and Approval (Humana Press Inc., Totowa, NJ, 1995) 23
• [32] A. Perzelova et al., Neoplasma 42, 25 (1998)
• [33] T. Mosmann, J. Immunol. Meth. 65, 55 (1983) http://dx.doi.org/10.1016/0022-1759(83)90303-4[Crossref]
• [34] E. Borenfreund, J. Puerner, Toxicol. Lett. 24, 119 (1985) http://dx.doi.org/10.1016/0378-4274(85)90046-3[Crossref]
• [35] K. Saotome, H. Morita, M. Umeda, Toxicol. In Vitro 3, 317 (1989) http://dx.doi.org/10.1016/0887-2333(89)90039-8[Crossref]
• [36] S.I.A. Wahab et al., J. Biomed. Biotechnol. 769568 (2009)
• [37] B.C. Pressman, M. Fashin, Ann. Rev. Pharm. Toxicol. 22, 465 (1982) http://dx.doi.org/10.1146/annurev.pa.22.040182.002341[Crossref]
• [38] K. Nakazato, Y. Hatano, Biochim. Biophys. Acta 1064, 103 (1991) http://dx.doi.org/10.1016/0005-2736(91)90416-6[Crossref]
• [39] W.H. Zhu, T T. Loh, Biochim. Biophys. Acta - Mol. Cell Res. 1269, 122 (1995) http://dx.doi.org/10.1016/0167-4889(95)00102-X[Crossref]
• [40] S. Grinstein, D. Rotin, M.J. Mason, Biochim. Biophys. Acta 988, 73 (1989) http://dx.doi.org/10.1016/0304-4157(89)90004-X[Crossref]
• [41] M. Bental, C. Deutsch, Am. J. Physiol. 266, 541C (1994)
• [42] G.N. Rao, N. de Roux, C. Sardet, J. Pouyssegur, B.C. Berk, J. Biol. Chem. 266, 13485 (1991)
• [43] J.M. Cobo et al., J. Cell. Physiol. 175, 59 (1998) http://dx.doi.org/10.1002/(SICI)1097-4652(199804)175:1<59::AID-JCP7>3.0.CO;2-B[Crossref]
• [44] S.W. Jacob, In: S.W. Jakob, E.E. Rosenbaun, D.C. Wood (Eds.), Dimethyl sulfoxide, vol. 1. Basic concepts of DMSO (Marcel Dekker Ink., New York, 1971) 99
• [45] N.C. Santos, J. Figueira-Coelho, J. Martins-Silva, C. Saldanha, Biochem. Pharm. 65, 1035 (2003) http://dx.doi.org/10.1016/S0006-2952(03)00002-9[Crossref]
• [46] K.S. Smalley, M. Lioni, M. Herlyn, In Vitro Cell Dev. Biol. - Animal 42, 242 (2006) http://dx.doi.org/10.1290/0604027.1[Crossref]
• [47] J. Lee et al., Small 5, 1213 (2009)
• [48] A.C. Souza et al., J. Vet. Med. A - Physiol. Pathol. Clin. Med. 52, 230 (2005) http://dx.doi.org/10.1111/j.1439-0442.2005.00728.x[Crossref]
• [49] R. Alexandrova, Exp. Pathol. Parasitol. 4, 57 (2001)

Identifiers

DOI

10.2478/s11532-012-0071-9